129 related articles for article (PubMed ID: 27754705)
1. Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal Cancer.
Jiang G; Luo C; Sun M; Zhao Z; Li W; Chen K; Fan T
Genet Test Mol Biomarkers; 2016 Nov; 20(11):710-714. PubMed ID: 27754705
[TBL] [Abstract][Full Text] [Related]
2. CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway.
Graule J; Uth K; Fischer E; Centeno I; Galván JA; Eichmann M; Rau TT; Langer R; Dawson H; Nitsche U; Traeger P; Berger MD; Schnüriger B; Hädrich M; Studer P; Inderbitzin D; Lugli A; Tschan MP; Zlobec I
Clin Epigenetics; 2018 Sep; 10(1):120. PubMed ID: 30257705
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation downregulates CDX2 expression in colorectal carcinomas.
Kawai H; Tomii K; Toyooka S; Yano M; Murakami M; Tsukuda K; Shimizu N
Oncol Rep; 2005 Mar; 13(3):547-51. PubMed ID: 15706431
[TBL] [Abstract][Full Text] [Related]
4. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
[TBL] [Abstract][Full Text] [Related]
5. SOX2 Inhibition Promotes Promoter Demethylation of CDX2 to Facilitate Gastric Intestinal Metaplasia.
Niu H; Jia Y; Li T; Su B
Dig Dis Sci; 2017 Jan; 62(1):124-132. PubMed ID: 27913994
[TBL] [Abstract][Full Text] [Related]
6. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
[TBL] [Abstract][Full Text] [Related]
7. The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas.
Witek ME; Nielsen K; Walters R; Hyslop T; Palazzo J; Schulz S; Waldman SA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8549-56. PubMed ID: 16361536
[TBL] [Abstract][Full Text] [Related]
8. Reduced Caudal Type Homeobox 2 (CDX2) Promoter Methylation Is Associated with Curcumin's Suppressive Effects on Epithelial-Mesenchymal Transition in Colorectal Cancer Cells.
Chen T; Yang C; Xi Z; Chen F; Li H
Med Sci Monit; 2020 Sep; 26():e926443. PubMed ID: 32893845
[TBL] [Abstract][Full Text] [Related]
9. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
10. CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer.
Olsen J; Eiholm S; Kirkeby LT; Espersen ML; Jess P; Gögenür I; Olsen J; Troelsen JT
Exp Mol Pathol; 2016 Feb; 100(1):59-66. PubMed ID: 26551082
[TBL] [Abstract][Full Text] [Related]
11. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the CDX2 promoter in Helicobacter pylori-infected gastric mucosa increases with age and its rapid demethylation in gastric tumors is associated with upregulated gene expression.
Kim HJ; Seo EH; Bae DH; Haam K; Jang HR; Park JL; Kim JH; Kim M; Kim SY; Jeong HY; Song KS; Kim YS
Carcinogenesis; 2020 Oct; 41(10):1341-1352. PubMed ID: 32706861
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer].
Tu XH; Huang SX; Li WS; Song JX
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):351-5. PubMed ID: 24054011
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
[TBL] [Abstract][Full Text] [Related]
15. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
[TBL] [Abstract][Full Text] [Related]
16. CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal Carcinoma.
Slik K; Turkki R; Carpén O; Kurki S; Korkeila E; Sundström J; Pellinen T
Am J Surg Pathol; 2019 Nov; 43(11):1473-1482. PubMed ID: 31490234
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Cdx2 protein in colorectal cancer].
Pack JH; Kim TD; Oh HA; Lee EJ; Kim JW; Jang BI; Kim TN; Jung MK; Bae YK
Korean J Gastroenterol; 2005 Sep; 46(3):204-10. PubMed ID: 16179840
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of CDX2 and Villin Expression in Advanced Stage Colorectal Carcinoma.
Altintas S; Bayrak M; Altintas Y
J Coll Physicians Surg Pak; 2019 Nov; 29(11):1057-1061. PubMed ID: 31659962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
